SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Natco Pharma informs about newspaper publication

03 Sep 2022 Evaluate
Pursuant to Regulations 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Natco Pharma has informed that it enclosed the copy of the notice issued in the newspapers Financial Express and Nava Telangana on September 3, 2022, regarding the notice of 39th Annual General Meeting, remote E-voting and matters related thereto. The above said newspaper advertisements are also updated on the website of the Company at www.natcopharma.co.in

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

1103.90 -20.55 (-1.83%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×